Table 2. Patient characteristics and association with using arteriovenous fistula and arteriovenous graft among end-stage renal disease hemodialysis patients.
| Patients Using an AVF (n = 37771) | Patients Using an AVG (n = 4473) | P value | |||
|---|---|---|---|---|---|
| n | (%) | n | (%) | ||
| Sex | <0.001 | ||||
| Female | 18327 | (86.6) | 2841 | (13.4) | |
| Male | 19444 | (92.3) | 1632 | (7.7) | |
| Age (years) | <0.001 | ||||
| 18–44 | 5058 | (94.5) | 296 | (5.5) | |
| 45–64 | 17446 | (91.3) | 1671 | (8.7) | |
| ≥ 65 | 15267 | (85.9) | 2506 | (14.1) | |
| Time of vascular access creation | <0.001 | ||||
| After initiating dialysis | 13214 | (91.6) | 1209 | (8.4) | |
| 0–1 month before dialysis | 13323 | (87.8) | 1843 | (12.2) | |
| ≥ 1 month before dialysis | 11234 | (88.8) | 1421 | (11.2) | |
| Diabetic mellitus | <0.001 | ||||
| No | 18943 | (90.6) | 1954 | (9.4) | |
| Yes | 18828 | (88.2) | 2519 | (11.8) | |
| Hypertension | 0.232 | ||||
| No | 7144 | (89.8) | 813 | (10.2) | |
| Yes | 30627 | (89.3) | 3660 | (10.7) | |
| Coronary artery disease | <0.001 | ||||
| No | 29122 | (90.1) | 3204 | (9.9) | |
| Yes | 8649 | (87.2) | 1269 | (12.8) | |
| Ischemic cerebrovascular disease | <0.001 | ||||
| No | 35791 | (89.6) | 4139 | (10.4) | |
| Yes | 1980 | (85.6) | 334 | (14.4) | |
| Deep venous thrombosis | 0.039 | ||||
| No | 37533 | (89.4) | 4433 | (10.6) | |
| Yes | 238 | (85.6) | 40 | (14.4) | |
| Peripheral artery disease | 0.005 | ||||
| No | 36654 | (89.5) | 4307 | (10.5) | |
| Yes | 1117 | (87.1) | 166 | (12.9) | |
| Dyslipidemia | 0.427 | ||||
| No | 31310 | (89.4) | 3729 | (10.6) | |
| Yes | 6461 | (89.7) | 744 | (10.3) | |
| Hyperuricemia | 0.129 | ||||
| No | 32371 | (89.3) | 3871 | (10.7) | |
| Yes | 5400 | (90.0) | 602 | (10) | |
| Chronic liver disease | 0.131 | ||||
| No | 34431 | (89.5) | 4047 | (10.5) | |
| Yes | 3340 | (88.7) | 426 | (11.3) | |
| Drug Usage (%) | |||||
| ACE-I | 10.7% | 6.2% | <0.001 | ||
| ARB | 15.0% | 7.1% | <0.001 | ||
| CCB | 32.2% | 20.6% | <0.001 | ||
AVF: arteriovenous fistula; AVG: arteriovenous graft; ACE-I: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker.